{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T16:13:08Z","timestamp":1788970388414,"version":"build-2803163510"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010648","name":"Universitaire Ziekenhuizen Leuven, KU Leuven","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010648","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"FWO","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004040","name":"KU Leuven","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004040","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Diagnostic Pathology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.anndiagpath.2026.152701","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T06:47:15Z","timestamp":1784702835000},"page":"152701","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Distinguishing EBV-positive classic Hodgkin lymphoma from EBV-positive DLBCL, NOS: diagnostic value and limits of immunohistochemical markers"],"prefix":"10.1016","volume":"85","author":[{"given":"Johanna","family":"Vets","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Lisa Vivian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Marcelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Van Ham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucienne","family":"Michaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"De Keersmaeker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xenia","family":"Haest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leandro","family":"Bomans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Vandenberghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Sagaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daan","family":"Dierickx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Tousseyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.anndiagpath.2026.152701_bb0005","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1182\/blood.2022015851","article-title":"The International Consensus Classification of mature lymphoid neoplasms: a report from the Clinical Advisory Committee","volume":"140","author":"Campo","year":"2022","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.anndiagpath.2026.152701_bb0010","doi-asserted-by":"crossref","first-page":"3715","DOI":"10.1182\/blood-2007-05-090142","article-title":"Epstein-Barr virus latent membrane protein 2A is a B-cell receptor mimic and essential for B-cell survival","volume":"110","author":"Mancao","year":"2007","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.anndiagpath.2026.152701_bb0015","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/path.2384","article-title":"The Epstein\u2013Barr virus oncoprotein, latent membrane protein-1, reprograms germinal centre B cells towards a Hodgkin\u2019s Reed\u2013Sternberg-like phenotype","volume":"216","author":"Vockerodt","year":"2008","journal-title":"J Pathol"},{"issue":"12","key":"10.1016\/j.anndiagpath.2026.152701_bb0020","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1136\/jcp.2007.050146","article-title":"Contribution of the Epstein\u2013Barr virus to the molecular pathogenesis of Hodgkin lymphoma","volume":"60","author":"Kapatai","year":"2007","journal-title":"J Clin Pathol"},{"issue":"1","key":"10.1016\/j.anndiagpath.2026.152701_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2025.100950","article-title":"Redefining the spectrum of Epstein-Barr virus\u2013positive (EBV+) diffuse large B-cell lymphoma and EBV+ classic Hodgkin lymphoma","volume":"39","author":"Nagase","year":"2026","journal-title":"Mod Pathol"},{"issue":"17","key":"10.1016\/j.anndiagpath.2026.152701_bb0030","doi-asserted-by":"crossref","first-page":"5124","DOI":"10.1158\/1078-0432.CCR-06-2823","article-title":"Age-related EBV-associated B-cell lymphoproliferative disorders constitute a distinct clinicopathologic group: a study of 96 patients","volume":"13","author":"Oyama","year":"2007","journal-title":"Clin Cancer Res"},{"issue":"12","key":"10.1016\/j.anndiagpath.2026.152701_bb0035","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1111\/j.1349-7006.2000.tb00909.x","article-title":"The characteristics of Epstein-Barr virus (EBV)-positive diffuse large B-cell lymphoma: comparison between EBV(+) and EBV(\u2212) cases in Japanese population","volume":"91","author":"Kuze","year":"2000","journal-title":"Jpn J Cancer Res"},{"key":"10.1016\/j.anndiagpath.2026.152701_bb0040","series-title":"The international consensus classification of myeloid and lymphoid neoplasms","first-page":"573","article-title":"Classic Hodgkin lymphoma","author":"Brousset","year":"2025"},{"issue":"5","key":"10.1016\/j.anndiagpath.2026.152701_bb0045","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1309\/YCH8DWUFFQBKGPVB","article-title":"The B-cell transcription factors BSAP, Oct-2, and BOB.1 and the Pan\u2013B-cell markers CD20, CD22, and CD79a are useful in the differential diagnosis of classic Hodgkin lymphoma","volume":"120","author":"Browne","year":"2003","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.anndiagpath.2026.152701_bb0050","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.anndiagpath.2019.02.001","article-title":"American Registry of Pathology Expert Opinions: immunohistochemical evaluation of classic Hodgkin lymphoma","volume":"39","author":"O\u2019Malley","year":"2019","journal-title":"Ann Diagn Pathol"},{"issue":"10","key":"10.1016\/j.anndiagpath.2026.152701_bb0055","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.3324\/haematol.11523","article-title":"A clinicopathological study of B-cell differentiation markers and transcription factors in classical Hodgkin\u2019s lymphoma: a potential prognostic role of MUM1\/IRF4","volume":"92","author":"Valsami","year":"2007","journal-title":"Haematologica"},{"issue":"7","key":"10.1016\/j.anndiagpath.2026.152701_bb0060","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/modpathol.2012.52","article-title":"EBV-positive diffuse large B-cell lymphoma of the elderly is an aggressive post-germinal center B-cell neoplasm characterized by prominent nuclear factor-kB activation","volume":"25","author":"Montes-Moreno","year":"2012","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.anndiagpath.2026.152701_bb0065","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/ajcp\/aqac105","article-title":"How I diagnose EBV-positive B- and T-cell lymphoproliferative disorders","volume":"159","author":"Dojcinov","year":"2023","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.anndiagpath.2026.152701_bb0070","series-title":"Age-related Epstein-Barr Virus (EBV)-associated B-cell lymphoproliferative disorders: comparison with EBV-positive classic Hodgkin lymphoma in elderly patients","author":"Asano","year":"2009"},{"key":"10.1016\/j.anndiagpath.2026.152701_bb0075","doi-asserted-by":"crossref","DOI":"10.4274\/tjh.galenos.2024.2024.0237","article-title":"GATA3 immunohistochemical staining in classical Hodgkin lymphoma and its diagnostic utility in differential diagnosis","author":"Altay","year":"2024","journal-title":"Turk J Hematol"},{"issue":"1","key":"10.1016\/j.anndiagpath.2026.152701_bb0080","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0002-9440(10)62238-9","article-title":"Expression of the T-cell transcription factors, GATA-3 and T-bet, in the neoplastic cells of Hodgkin lymphomas","volume":"166","author":"Atayar","year":"2005","journal-title":"Am J Pathol"},{"issue":"3","key":"10.1016\/j.anndiagpath.2026.152701_bb0085","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/PAI.0000000000000581","article-title":"GATA3 immunohistochemical staining in Hodgkin lymphoma: diagnostic utility in differentiating classic Hodgkin lymphoma from nodular lymphocyte predominant Hodgkin lymphoma and other mimicking entities","volume":"27","author":"Kezlarian","year":"2019","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"1","key":"10.1016\/j.anndiagpath.2026.152701_bb0090","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s13000-019-0918-x","article-title":"Comparative pathologic analysis of mediastinal B-cell lymphomas: selective expression of p63 but no GATA3 optimally differentiates primary mediastinal large B-cell lymphoma from classic Hodgkin lymphoma","volume":"14","author":"Kim","year":"2019","journal-title":"Diagn Pathol"},{"issue":"1","key":"10.1016\/j.anndiagpath.2026.152701_bb0095","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/00000478-200301000-00003","article-title":"Senile EBV+ B-cell lymphoproliferative disorders a clinicopathologic study of 22 patients","volume":"27","author":"Oyama","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2026.152701_bb0100","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00428-022-03414-4","article-title":"New concepts in EBV-associated B, T, and NK cell lymphoproliferative disorders","author":"Quintanilla-Martinez","year":"2023","journal-title":"Virchows Arch"},{"issue":"10","key":"10.1016\/j.anndiagpath.2026.152701_bb0110","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1016\/j.humpath.2013.04.011","article-title":"IMP3 as a supplemental diagnostic marker for Hodgkin lymphoma","volume":"44","author":"Tang","year":"2013","journal-title":"Hum Pathol"},{"issue":"1","key":"10.1016\/j.anndiagpath.2026.152701_bb0115","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1186\/s12885-022-10321-z","article-title":"The utility of IMP3 immunohistochemical staining in differentiating nodular lymphocyte predominant Hodgkin Lymphoma from T-Cell\/Histiocyte-Rich large B-Cell lymphoma","volume":"22","author":"Kosari","year":"2022","journal-title":"BMC Cancer"},{"issue":"13","key":"10.1016\/j.anndiagpath.2026.152701_bb0120","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1182\/blood.2020009265","article-title":"Taking gray zone lymphomas out of the shadows","volume":"137","author":"Campo","year":"2021","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.anndiagpath.2026.152701_bb0125","doi-asserted-by":"crossref","DOI":"10.3390\/cancers10090285","article-title":"Co-expression of the Epstein-Barr virus-encoded latent membrane proteins and the pathogenesis of classic Hodgkin lymphoma","volume":"10","author":"Vrzalikova","year":"2018","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.anndiagpath.2026.152701_bb0130","series-title":"Haematolymphoid tumours (WHO classification of tumours series)","author":"WHO Classification of Tumours Editorial Board","year":"2022"},{"issue":"3","key":"10.1016\/j.anndiagpath.2026.152701_bb0135","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/modpathol.2016.199","article-title":"Identification of distinct subgroups of EBV-positive post-transplant diffuse large B-cell lymphoma","volume":"30","author":"Morscio","year":"2017","journal-title":"Mod Pathol"},{"issue":"9","key":"10.1016\/j.anndiagpath.2026.152701_bb0140","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1097\/PAS.0000000000001654","article-title":"PD-1 and PD-L1 immunohistochemistry as a diagnostic tool for classic Hodgkin lymphoma in small-volume biopsies","volume":"45","author":"Uccella","year":"2021","journal-title":"Am J Surg Pathol"},{"issue":"16","key":"10.1016\/j.anndiagpath.2026.152701_bb0145","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1182\/bloodadvances.2021004515","article-title":"Clinicopathological features and survival in EBV-positive diffuse large B-cell lymphoma not otherwise specified","volume":"5","author":"Bourbon","year":"2021","journal-title":"Blood Adv"},{"issue":"1","key":"10.1016\/j.anndiagpath.2026.152701_bb0150","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-17204-5","article-title":"QuPath: open source software for digital pathology image analysis","volume":"7","author":"Bankhead","year":"2017","journal-title":"Sci Rep"},{"issue":"12","key":"10.1016\/j.anndiagpath.2026.152701_bb0155","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1038\/sj.leu.2403202","article-title":"Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936","volume":"17","author":"van Dongen","year":"2003","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.anndiagpath.2026.152701_bb0160","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00428-022-03414-4","article-title":"New concepts in EBV-associated B, T, and NK cell lymphoproliferative disorders","volume":"482","author":"Quintanilla-Martinez","year":"2023","journal-title":"Virchows Arch"},{"issue":"7","key":"10.1016\/j.anndiagpath.2026.152701_bb0165","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1182\/blood-2015-02-630632","article-title":"EBV-positive large B-cell lymphomas in young patients: a nodal lymphoma with evidence for a tolerogenic immune environment","volume":"126","author":"Nicolae","year":"2015","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.anndiagpath.2026.152701_bb0170","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00428-022-03427-z","article-title":"Evolution in the definition and diagnosis of the Hodgkin lymphomas and related entities","volume":"482","author":"Tousseyn","year":"2023","journal-title":"Virchows Arch"},{"issue":"12","key":"10.1016\/j.anndiagpath.2026.152701_bb0175","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1038\/modpathol.3800227","article-title":"Analysis of transcription factor OCT.1, OCT.2 and BOB.1 expression using tissue arrays in classical Hodgkin\u2019s lymphoma","volume":"17","author":"Garc\u00eda-Cos\u00edo","year":"2004","journal-title":"Mod Pathol"},{"key":"10.1016\/j.anndiagpath.2026.152701_bb0180","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/ajcp\/aqac105","article-title":"How I diagnose EBV-positive B- and T-cell lymphoproliferative disorders","author":"Dojcinov","year":"2023","journal-title":"Am J Clin Pathol"},{"issue":"1","key":"10.1016\/j.anndiagpath.2026.152701_bb0185","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1182\/hematology.2025000748C","article-title":"All shades of gray in the mediastinum: do we have bright ideas about how to diagnose and treat mediastinal gray zone lymphoma in the era of targeted agents?","volume":"2025","author":"Sarkozy","year":"2025","journal-title":"Hematology"},{"issue":"3","key":"10.1016\/j.anndiagpath.2026.152701_bb0190","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3960\/jslrt.20010","article-title":"Clinicopathological significance of CD79a expression in classic Hodgkin lymphoma","volume":"60","author":"Sakatani","year":"2020","journal-title":"J Clin Exp Hematop"},{"issue":"21","key":"10.1016\/j.anndiagpath.2026.152701_bb0195","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13215451","article-title":"New look of EBV LMP1 signaling landscape","volume":"13","author":"Wang","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.anndiagpath.2026.152701_bb0200","first-page":"1","article-title":"The Epstein-Barr virus in classical Hodgkin lymphoma: pathogenesis, immunobiology, and therapeutic implications","author":"Gandhi","year":"2025","journal-title":"Curr Top Microbiol Immunol"},{"issue":"20","key":"10.1016\/j.anndiagpath.2026.152701_bb0205","doi-asserted-by":"crossref","first-page":"4202","DOI":"10.1182\/blood-2010-01-265827","article-title":"Mechanisms of aberrant GATA3 expression in classical Hodgkin lymphoma and its consequences for the cytokine profile of Hodgkin and Reed\/Sternberg cells","volume":"116","author":"Stanelle","year":"2010","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.anndiagpath.2026.152701_bb0210","doi-asserted-by":"crossref","DOI":"10.3390\/diseases12030051","article-title":"Expression patterns of GATA3 in classical Hodgkin lymphoma: a clinico-pathological study","volume":"12","author":"Papoudou-Bai","year":"2024","journal-title":"Diseases"},{"issue":"5","key":"10.1016\/j.anndiagpath.2026.152701_bb0215","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.immuni.2013.01.014","article-title":"Transcriptional repression of Gata3 is essential for early B cell commitment","volume":"38","author":"Banerjee","year":"2013","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.anndiagpath.2026.152701_bb0225","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3892\/etm.2023.12294","article-title":"Expression of the immune checkpoint molecules PD-L1 and PD-1 in EBV-associated lymphoproliferative disorders: a meta-analysis","volume":"27","author":"Yu","year":"2023","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.anndiagpath.2026.152701_bb0230","series-title":"5th edition of the world health organization classification of haematolymphoid tumours","article-title":"EBV-positive diffuse large B-cell lymphoma","author":"Anagnostopoulos","year":"2022"},{"key":"10.1016\/j.anndiagpath.2026.152701_bb0235","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1034398","article-title":"The prognostic value of Epstein\u2212Barr virus infection in Hodgkin lymphoma: a systematic review and meta-analysis","volume":"12","author":"Hu","year":"2022","journal-title":"Front Oncol"},{"issue":"5","key":"10.1016\/j.anndiagpath.2026.152701_bb0240","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/s41408-021-00493-5","article-title":"Genomic insights into the pathogenesis of Epstein\u2013Barr virus-associated diffuse large B-cell lymphoma by whole-genome and targeted amplicon sequencing","volume":"11","author":"Gebauer","year":"2021","journal-title":"Blood Cancer J"},{"issue":"3","key":"10.1016\/j.anndiagpath.2026.152701_bb0245","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/s41375-022-01804-w","article-title":"Molecular profiling of EBV associated diffuse large B-cell lymphoma","volume":"37","author":"Frontzek","year":"2023","journal-title":"Leukemia"},{"key":"10.1016\/j.anndiagpath.2026.152701_bb0250","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2019.00683","article-title":"Comprehensive genomic profiling of EBV-positive diffuse large B-cell lymphoma and the expression and clinicopathological correlations of some related genes","volume":"9","author":"Zhou","year":"2019","journal-title":"Front Oncol"}],"container-title":["Annals of Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913426000973?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913426000973?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T15:31:59Z","timestamp":1788967919000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1092913426000973"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":48,"alternative-id":["S1092913426000973"],"URL":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2026.152701","relation":{},"ISSN":["1092-9134"],"issn-type":[{"value":"1092-9134","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Distinguishing EBV-positive classic Hodgkin lymphoma from EBV-positive DLBCL, NOS: diagnostic value and limits of immunohistochemical markers","name":"articletitle","label":"Article Title"},{"value":"Annals of Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2026.152701","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"152701"}}